Trending Now
1
Can SGLT2 Inhibitors Affect Dementia?
2
FDA Approves Oveporexton for Narcolepsy Type 1
3
FDA Approves At-Home Starting Dose for Lecanemab
4
Neurodegenerative Mortality May Be Higher in NFL Players
5
Medical Oddities: Shellfish Toxin? Send in the Frog
6
Remote Testing May Capture Subtle Changes in Early Alzheimer’s Disease
Conference Coverage
Cleveland Clinic's AI Summit
2026 ASRS Meeting
July 15, 2026
Lessons From the ARCHER Trial
July 15, 2026
Neuroprotection: Retina's Next Frontier?
2026 AOA
June 17, 2026
Oculomics: Beyond the Buzzword
Clinical Guidelines
View More
May 12, 2026
Astigmatism Up After COVID Restrictions
May 05, 2026
AAP Updates Pediatric Office Emergency Readiness
April 27, 2026
This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet
April 23, 2026
ASH 2025: Highlights in Relapsed/Refractory Multiple Myeloma
Commentary & Perspectives
View More
June 23, 2026
Side Effects: Sour Mouth, Lower BP
June 17, 2026
Autism Announcement Changes Search Behavior
June 08, 2026
When Autism Hope Outruns Evidence
May 29, 2026
Retinal Imaging AI May Flag Brain Health Risk
FDA & Government News
View More
August 06, 2026
FDA Approves Oveporexton for Narcolepsy Type 1
Business Management
View More
July 09, 2026
Top 10 Evidence-Based Essentials in Neurology
May 28, 2026
Top 10 States With Rising Demand for Physicians
May 01, 2026
